 |
 |
On Jan. 19, 1883, the town of Roselle, N.J., became the first of its kind to utilize an electric lighting system designed with overhead wires, providing empirical evidence that a community could be powered using a shared service. Now, 135 years later, we thrive on this principle: that a shared resource provides an efficient benefit to our community – and yes, electricity is certainly required.
As we enter 2018, the life sciences institutes will operate with this principle in mind. You will benefit from the individual institutes’ number of exciting resources – from increased leadership to new facilities and instrumentation, to name a few. As always, we are here to help.
Announcements
Upcoming events
As a reminder, you may change your preference or subscribe to this newsletter here. |
|
Welcome back to campus. We hope that you had a restful winter break and are ready for the new semester. Drug Discovery is preparing for the upcoming year by holding its first meeting with a newly formed leadership committee. One of the first orders of business is for the committee to review the findings from our recent town hall along with suggesting and prioritizing programs and activities to address these needs. We look forward to implementing these new programs throughout the coming year while continuing to
enhance drug discovery/development efforts at Purdue. Please stay tuned for more information.
Faculty members in the news
- Philip Low, Presidential Scholar for Drug Discovery, spoke at the Indian Institute of Technology Madras on new targeted therapies for diseases.
- Gaurav Chopra, Jeremy Lohman, Darci Trader and Qi (Tony) Zhou have all received Showalter Trust early-career grants.
Upcoming events
|
|
|
Dear PI4D members and friends:
As we venture into the new year, our thoughts are focused on the sustainability of our institute in order to build on a generation of investigators that build new tools and technologies to tackle disease detection, protection and prevention. We are exploring various mechanisms that will leverage the generous investment of our university in our institutes of life sciences.
One thrust area is within the scope of biological threat detection and mitigation in alignment with the Defense Threat Reduction Agency (DTRA). Ronald Hann Jr., director of the Chemical and Biological Technologies Department, will visit on Feb. 21 and spotlight how to work with DTRA. Save the date and watch for more details regarding the seminar location.
Stay warm!
Faculty members in the news
- Richard J. Kuhn, PI4D director, has a new title: the Krenicki Family Director in Inflammation, Immunology and Infectious Disease. The named directorship is being funded by a multimillion-dollar gift from the John Jr. and Donna Krenicki family. Kuhn also has been appointed to the Advisory Committee for Biological Sciences of the National Science Foundation for a two-year term.
- A grant application based on a PI4D incentive award submitted by PI4D member Zhao-Qing Luo and colleague Chittaaranjan Das has been funded by the National Institute of General Medical Sciences. The four-year grant totals more than $1.65 million.
Announcements
- Postdoctoral fellowship positions are now open in three laboratories of the National Institute of Allergy and Infectious Diseases.
- A post-doctoral position is immediately available in the laboratory of Ourania Andrisani, professor of basic medical sciences.
- Earlier this week, PI4D and the Department of Entomology jointly sponsored a presentation by Anthony James, the Donald Bren Professor of Microbiology and Molecular Genetics in the School of Medicine with the University of California – Irvine. James presented a seminar entitled "'La Zanzara Vitruviana': Synthetic Biology and Malaria." Thanks to all who attended the seminar.
Upcoming events
- As part of our Lecture Hall Series, Priya Prakash, PULSe student in the Department of Chemistry, will present “Neuro-Immune Interactions in Alzheimer's Disease” on Jan. 25.
|
|
|
Happy New Year, PIIN community!
PIIN’s administrative office has moved to LILY 2-228/229 while we await renovations on the third floor of the Hall for Discovery and Learning Research, where we will relocate at the beginning of the summer. In Lilly Hall, you can find Cinthia Sanchez (PIIN operations manager) and our new administrative assistant, Julie Scott. Julie has a bachelor of science in retail management from Purdue and has extensive administrative experience from her work in the private sector. Julie can be reached at scott498@purdue.edu. Welcome to the team, Julie!
We also welcome Gabriel Albors (goa@purdue.edu) as the director of the Neuroscience Animal Behavior Core facilities, which we are beginning to equip. Gabriel has a master’s degree in biomedical engineering from Purdue and extensive research, administration and management experience.
We are pleased to announce several local opportunities for sharing neuroscience research this spring (further details below). First, we will continue with our Brain and Spinal Cord Injury Seminar Series on alternate Wednesday afternoons in the DRUG lobby. Second, Purdue is hosting the Greater Indiana SfN Annual Meeting on March 23; please register soon! Third, PIIN is sponsoring Audition: From Neural Circuits to Perception as a Special Lectures in Neuroscience course. Both graduate students and postdocs are invited to participate.
Finally, congratulations to the recipients of the winter/spring cycle of travel grants:
- Emily Haynes – Matt Tantama's lab (CHEM)
-
MeeJung Ko – Richard Van Rijn's lab (MCMP)
-
Alex Pak – Alex Chubykin's lab (BIOL)
-
Satyabrata Parida – Mike Heinz's lab (SLHS)
-
Will Salloom – Beth Strickland's lab (SLHS)
-
Jiayue Cao – Zhongming Liu's lab (BME)
Upcoming events
Announcements
|
|
|
The Purdue University Center for Cancer Research (PCCR) was established by the National Cancer Institute as a basic science cancer center in 1978. As such, the PCCR’s mission focuses on basic discovery - discovery that is the foundation through which the PCCR fosters innovative cancer solutions. Your membership and contributions are key to fighting cancer! Please find updates below; you can always reference information on our website.
In the news
The PCCR has received a $10 million matching-funds gift from the Indianapolis-based Walther
Cancer Foundation to advance its research in drug discovery, treatments and potential cures. The gift is designed to inspire endowed gifts to Purdue’s center to sustain the center throughout its existence. It is the latest gift from the Walther Cancer Foundation, which has given more than $16 million in grants to Purdue over the years. Read more in this news release from Purdue. Watch a video from local TV station WLFI.
Upcoming events
- As part of our Cancer Center Seminar Series, Heather Hundley, assistant professor of biochemistry and molecular biology in the Medical Sciences Program at the Indiana University School of Medicine, will give a talk titled "Identification of a Key Regulator of RNA Editing in Glioblastoma" at 11:30 a.m., Thurs., Jan. 25 in the Drug Discovery Conference Room.
- For more information on upcoming seminars, internal and external funding opportunities, and events, see our calendar.
|
|
|
Welcome back! We are thrilled to have a busy start to 2018. With abundant opportunities on the horizon for RCHE, there are a select number of strategic areas that we expect will play a large role in our development this year. As you may recall from a previous communication, we have open faculty positions, and have identified some very good candidates. We will keep you posted when we have some exciting additions to the RCHE community.
Additionally, we are looking forward to the development of the Data Science Initiative as data is integral to every portion of our mission. As a reminder, the data science forum will be held on Fri., Jan. 26 where we will hear next steps regarding the initiative. The event will be held from 10-11:30 a.m. in Fowler Hall, Stewart Center.
|
|
|
|
|
|
|
|
 |
|
|
